Literature DB >> 30893216

Short Versus Long InterTAN Fixation for Geriatric Intertrochanteric Hip Fractures: A Multicentre Head-to-Head Comparison.

Michael Sellan1, Dianne Bryant1, Christina Tieszer1, Steven Papp2, Abdel Lawendy1, Allan Liew2, Darius Viskontas3, Mark MacLeod1, Chad Coles4, Tim Carey1, Wade Gofton2, Andrew Trenholm4, Trevor Stone3, Ross Leighton4, David Sanders1.   

Abstract

OBJECTIVE: To determine if geriatric intertrochanteric hip fracture patients achieve equivalent postoperative functional status after management with either a short (180-200 mm) or a long (260-460 mm) InterTAN intramedullary device.
DESIGN: Retrospective review of a prospective randomized control trial.
SETTING: Four Level I Trauma Centers. PATIENTS/PARTICIPANTS: One hundred eight patients with OTA/AO classification 31A-1 and 31A-2 intertrochanteric hip fractures were included in the study. INTERVENTION: Internal fixation using an IT device. MAIN OUTCOMES MEASURES: Primary outcomes included Functional Independence Measure and Timed Up and Go. Secondary outcomes included blood loss, surgical time, length of stay, adverse events, and mortality.
RESULTS: Seventy-one short and 37 long IT patients met study inclusion criteria. Demographics were similar between groups. There was no difference in Functional Independence Measure or Timed Up and Go scores between the 2 IT groups at any of the time points collected. Mean operative time was lower in the short IT group than in the long IT group (60 vs. 73 minutes; P = 0.021). A higher proportion of long IT patients had reamed constructs (95% vs. 48% short IT, P < 0.001). Postoperative blood loss was significantly higher in the long IT group without a significant influence on the number of patients requiring transfusion (P = 0.582) or average units transfused (P = 0.982). There was no significant difference in the proportion of postoperative adverse events between the 2 cohorts despite a higher number of peri-implant femur fractures in the short IT group than in the long IT group (5 vs. 1, P = 0.350).
CONCLUSIONS: Postoperative functional status was not influenced by the length of IT device in the management of geriatric intertrochanteric hip fractures. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2019        PMID: 30893216     DOI: 10.1097/BOT.0000000000001409

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  5 in total

1.  How are peri-implant fractures below short versus long cephalomedullary nails different?

Authors:  L Henry Goodnough; Brett P Salazar; Jamie Furness; James E Feng; Malcolm R DeBaun; Sean T Campbell; Justin F Lucas; William W Cross; Philipp Leucht; Kevin D Grant; Michael J Gardner; Julius A Bishop
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-09-09

2.  Short vs. long intramedullary nail systems in trochanteric fractures: A randomized prospective single center study.

Authors:  Șerban Dragosloveanu; Christiana D M Dragosloveanu; Dragoș C Cotor; Cristian I Stoica
Journal:  Exp Ther Med       Date:  2021-12-01       Impact factor: 2.447

3.  Development of a Nomogram to Predict Postoperative Transfusion in the Elderly After Intramedullary Nail Fixation of Femoral Intertrochanteric Fractures.

Authors:  Jiqi Wang; Youming Zhao; Bingjie Jiang; Xiaojing Huang
Journal:  Clin Interv Aging       Date:  2021-01-06       Impact factor: 4.458

4.  Clinical outcomes following long versus short cephalomedullary devices for fixation of extracapsular hip fractures: a systematic review and meta-analysis.

Authors:  Gabriel Kai Yang Tan; Christoph Sheng Chong; Hamid Rahmatullah Bin Abd Razak
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.379

5.  The predictive value of the Singh index for the risk of InterTAN intramedullary fixation failure in elderly patients with intertrochanteric fractures.

Authors:  Zhe Xu; Guang Tian; Chen Liu; Yangjiang Xie; Ruguo Zhang
Journal:  BMC Musculoskelet Disord       Date:  2022-08-12       Impact factor: 2.562

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.